NIO CEO Media Tour in NYC Gets Results
Yesterday, I hosted NIO's annual public neurotech company CEO media tour here in NYC with Uli Hacksell, CEO of Acadia Pharmaceuticals, Ron Cohen, CEO of Acorda Therapeutics and Joern Aldag, CEO of Evotec joining me in hour long discussions with reporters at the Wall Street Journal, BusinessWeek, PharmaWire (Financial Times), Discover Magazine, and Forbes. The discussions were lively and revolved around the impact of the current financial crisis as well as the lack of adequate regulatory resources. The Wall Street Journal picked up on our conversation and posted some of it on the WSJ Health Blog: FDA Delays Take Toll on Neuroscience Drug Developmentposted by Shirley S. Wang.
"The FDA has even the neuroscience crowd scratching their heads.
Some folks from the Neurotechnology Industry Organization, a trade group for neuroscience companies, and three of its members stopped by Health Blog HQ today. Our chat really heated up when it turned to the current regulatory environment...(more)